IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management I, LLC

Q1 2014 Holdings

Filed 2014-05-15 | 11 holdings | $142.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Karyopharm Therapeutics Inc.(KPTIEUR)COM48576U106$49.0K1,585,74334.4%
Keryx Biopharmaceuticals Inc.COM492515101$22.4K1,312,00615.7%
Ambit Biosciences CorporationCOM02318X100$19.0K2,079,56913.3%
Acelrx Pharmaceuticals, Inc.(ACRXUSD)COM00444T100$16.6K1,379,08011.6%
Xencor, Inc.(XNCR)COM98401F105$9.6K820,0006.8%
Orexigen Therapeutics, Inc.COM686164104$8.1K1,250,0005.7%
Novavax Inc.COM670002104$6.1K1,336,2004.3%
BioDelivery Sciences International, Inc.(BDSIUSD)COM09060J106$5.9K700,0004.2%
Ignyta, Inc.COM451731103$4.2K500,0002.9%
Novavax Inc.PutCOM670002104$9062,0000.6%
Acceleron Pharma Inc.(XLRN)COM00434H108$72120,8920.5%